In recent years, many researchers have been focused on DCIS: ductal carcinoma in situ, the earliest stage of cancer that in most cases remains in the milk ducts and does not invade other tissues.

A newly released study is challenging the way doctors commonly treat patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer. DCIS cancer cells are confined inside a milk ...

DURHAM, N.C. – The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely ...

Ductal carcinoma in situ, or DCIS, accounts for up to 25% of diagnosed breast cancers and affects more than 50,000 women each year, according to the American Cancer Society. Often called “sta ...

“All current treatments for DCIS aim to reduce the risk of future invasive cancer, despite a growing body of evidence that not all DCIS is destined to progress,” said Dr. Shelley Hwang, a professor of ...

Each year, more than 56,500 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive type of breast cancer commonly referred to as Stage 0 breast cancer. A woman with DCIS is ...

Study reveals short term safety of active monitoring for ductal carcinoma in situ. ScienceDaily . Retrieved January 5, 2025 from www.sciencedaily.com / releases / 2024 / 12 / 241212115836.htm ...

FRIDAY, Dec. 13, 2024 (HealthDay News) -- For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) that involves surgery with or ...

Women who took tamoxifen after undergoing a lumpectomy to remove ductal carcinoma in situ (DCIS) were 44% to 51% less likely to have their cancer return in that breast, researchers reported last ...

According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal carcinoma in situ (DCIS) resulted in breast cancer recurrence rates similar ...

Opens in a new tab or window SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended ...

The term 'overdiagnosis' refers to the detection of subclinical disease that, if left untreated, would never cause symptoms or death during the patient's lifetime. The term 'false-positive ...